Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_assertion type Assertion NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_head.
- NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_assertion description "[Knockdown of PHD2 in 786-O VHL(+) cells resulted in a more malignant phenotype in orthotopic xenografts and higher expression of specific cell cycle regulators (CDC25A, cyclin-dependent kinase 2, CCNA2) compared with VHL(-) RCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_provenance.
- NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_assertion evidence source_evidence_literature NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_provenance.
- NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_assertion SIO_000772 20978146 NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_provenance.
- NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_assertion wasDerivedFrom befree-20150227 NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_provenance.
- NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_assertion wasGeneratedBy ECO_0000203 NP287577.RA4CanA2u2P5fZ7fkkRXSzTte_BFyG5Ew9SjihDZcrLUk130_provenance.